Clinical Trials Browser

Phase 2 × Melanoma × Rituximab × Clear all

NCT03719131 2025-04-22

Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy

Phase 2 Active not recruiting

15 enrolled 10 charts

Melanoma

NCT02142335 2014-05-20

Rituxan and Abraxane for the Treatment of Patients With Inoperable Stage III and IV Malignant Melanoma

Phase 2 Unknown

Melanoma